VIVUS (STU:VIU1) Change In Inventory : €-14.15 Mil (TTM As of Mar. 2020)

View and export this data going back to . Start your Free Trial

What is VIVUS Change In Inventory?

VIVUS's change in inventory for the quarter that ended in Mar. 2020 was €-1.84 Mil. It means VIVUS's inventory increased by €1.84 Mil from Dec. 2019 to Mar. 2020 .

VIVUS's change in inventory for the fiscal year that ended in Dec. 2019 was €-11.36 Mil. It means VIVUS's inventory increased by €11.36 Mil from Dec. 2018 to Dec. 2019 .

VIVUS's Total Inventories for the quarter that ended in Mar. 2020 was €30.71 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. VIVUS's Days Inventory for the quarter that ended in Mar. 2020 was 664.96.

Inventory Turnover measures how fast the company turns over its inventory within a year. VIVUS's Inventory Turnover for the quarter that ended in Mar. 2020 was 0.14.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. VIVUS's Inventory-to-Revenue for the quarter that ended in Mar. 2020 was 1.72.

VIVUS Change In Inventory Historical Data

The historical data trend for VIVUS's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIVUS Change In Inventory Chart

VIVUS Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Change In Inventory

Get a 7-Day Free Trial

-7.79

-2.45

-1.29

-5.14

-11.36

VIVUS Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Change In Inventory	Get a 7-Day Free Trial															1.05	-7.47	-0.74	-4.10	-1.84

VIVUS Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was €-14.15 Mil.

VIVUS (STU:VIU1) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

VIVUS's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	30.5115	/	4.187	*	365 / 4
	=	664.96

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

VIVUS's Inventory Turnover for the quarter that ended in Mar. 2020 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	4.187	/	30.5115
	=	0.14

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

VIVUS's Inventory to Revenue for the quarter that ended in Mar. 2020 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	30.5115	/	17.766
	=	1.72

VIVUS Change In Inventory Related Terms

Thank you for viewing the detailed overview of VIVUS's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

VIVUS (STU:VIU1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VIVUS Inc (STU:VIU1) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 East Hamilton Avenue, Suite 550, Campbell, CA, USA, 95008

Website

http://www.vivus.com

VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.

VIVUS (STU:VIU1) Headlines

No Headlines